ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,876Medicare Part D Prescriptions Filled, Including Refills

Rank: 205 out of 1206

$506K Total Retail Price of All Prescriptions

Rank: 162 out of 1206

386 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
32% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Iowa
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 386 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

14% of this provider’s 386 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 8,073 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $46 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Iowa
SIMVASTATIN 433 373 1 1
LISINOPRIL 380 334 2 4
OMEPRAZOLE 330 295 3 3
HYDROCODONE-ACETAMINOPHEN 272 192 S3 4 7
HYDROCHLOROTHIAZIDE 248 226 5 11
AMLODIPINE BESYLATE 234 231 6 6
CITALOPRAM HBR 220 163 7 16
LEVOTHYROXINE SODIUM 215 170 8 2
FUROSEMIDE 214 182 9 5
METFORMIN HCL 157 125 10 10
CARVEDILOL 157 141 10 32
BUPROPION XL 145 105 12 151
TRAMADOL HCL 137 105 13 17
ZOLPIDEM TARTRATE 130 97 14 25
PRAVASTATIN SODIUM 126 115 15 21
PRAMIPEXOLE DIHYDROCHLORIDE 126 106 15 142
WARFARIN SODIUM 119 114 17 8
GABAPENTIN 113 79 18 18
BENAZEPRIL HCL 108 108 19 39
PREDNISONE 104 95 20 28
ATORVASTATIN CALCIUM 103 97 21 13
ALENDRONATE SODIUM 95 82 22 19
SERTRALINE HCL 95 77 22 22
PROAIR HFA 93 70 24 49
AMITRIPTYLINE HCL 92 76 R 25 59
CRESTOR 89 85 26 30
LOSARTAN POTASSIUM 83 59 27 20
METOPROLOL TARTRATE 79 68 28 9
ALLOPURINOL 79 69 28 24
CARBIDOPA-LEVODOPA 78 78 30 70
PANTOPRAZOLE SODIUM 78 60 30 54
NAMENDA 76 66 32 36
POTASSIUM CHLORIDE 74 74 33 12
GLIPIZIDE ER 74 62 33 99
PAROXETINE HCL 68 63 35 53
LEVEMIR FLEXPEN 68 62 35 217
ATENOLOL 67 59 37 14
AZITHROMYCIN 67 51 37 46
FENTANYL 66 53 S2 39 51
PEN NEEDLE 65 49 40 121
OXYBUTYNIN CHLORIDE 64 64 41 68
DONEPEZIL HCL 63 52 42 29
TRAZODONE HCL 62 43 43 37
METOPROLOL SUCCINATE 59 59 44 15
FELODIPINE ER 56 56 45 171
FLOVENT HFA 56 31 45 228
CLOPIDOGREL 56 56 45 48
LANTUS 55 41 48 38
TRIAMTERENE-HCTZ 55 54 48 33
CIPROFLOXACIN HCL 54 50 50 61
QUINAPRIL HCL 53 52 51 117
ADVAIR DISKUS 53 39 51 55
BENAZEPRIL-HYDROCHLOROTHIAZIDE 52 51 53 133
FLUTICASONE PROPIONATE 50 44 54 42
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.